Which service fits your task?

Several treatment routes exist for cancer, a rare condition or serious complex illness. You need to understand what each means for this patient.

What the fee pays for

Assessment CNY 3,000; stage CNY 29,800–98,000. Clients decide whether to proceed after assessment. Credit the assessment against the same-scope full commission. New clinical stages, questions or record batches require an agreed change.

Value beyond this task

Agreed professional review record, unresolved issues and an update baseline. Illustrative total CNY 48,000 includes the CNY 3,000 assessment. This is not a completed client case, overseas specialist fee or treatment charge. Acceptance depends on the agreed work and traceable deliverables, not treatment changes, cost savings or survival improvement.

How to assess value

Check responses to the agreed questions, traceable sources, record gaps and differing opinions. For overseas routes, also check incremental services and third-party fees. Clinical outcomes are not consulting acceptance criteria.

Personal evidence consulting is not oncology treatment, pathological diagnosis or prescribing. Relevant specialist qualifications and review responsibilities must be confirmed before accepting a cancer or rare-condition commission. The patient and treating team make the treatment decision.

You can commit a substantial treatment budget, but first want to know what overseas care may add medically.

What the fee pays for

Assessment CNY 3,000; stage CNY 50,000–150,000. Agree new institutions, proposals, opinion reviews or record changes before work. Identify and credit reusable work first. Travel and hospital admission are not required next purchases.

Value beyond this task

Evidence differences after outside opinions and questions about continuity with local care. Illustrative service total CNY 88,000 includes CNY 3,000 assessment; external consultation, treatment, professional translation, travel and transport are excluded. Confirm hospital eligibility and prices directly; no partnership or appointment access is claimed.

How to assess value

Check responses to the agreed questions, traceable sources, record gaps and differing opinions. For overseas routes, also check incremental services and third-party fees. Clinical outcomes are not consulting acceptance criteria.

No guaranteed appointment, visa, trial enrolment, medicine access, transport or outcome. Hospital, clinician, professional translation and travel charges are separate. Institutions verify referral and practice requirements. Treating and transport clinicians determine fitness for critical-care transfer.

A new test, study or outside opinion arrives. You need to know what changed in the earlier comparison.

What the fee pays for

CNY 8,000–30,000 per agreed window. Choose any further window separately. New questions or treatment stages require a new scope. This is not unlimited year-round advice.

Value beyond this task

Record gaps, questions for clinicians and a version history. Illustrative total CNY 12,000 covers only the agreed 14-day window and two questions. Continuous standby, an outside medical appointment and a new full evidence topic are excluded.

How to assess value

Check responses to the agreed questions, traceable sources, record gaps and differing opinions. For overseas routes, also check incremental services and third-party fees. Clinical outcomes are not consulting acceptance criteria.

No continuous monitoring, emergency consultation or treatment orders. When care cannot wait, the treating team handles the current decision first; evidence work proceeds only within a feasible waiting window.

Understand one question before your appointment.

What the fee pays for

CNY 99 per request. No automatic renewal. Deliverables include a 30-day download window. New questions or a new batch of records require scope confirmation first.

Value beyond this task

A list of questions to bring to your clinician. Charges end when this deliverable is complete. Missing records are not filled in with invented normal values.

How to assess value

Check responses to the agreed questions, traceable sources, record gaps and differing opinions. For overseas routes, also check incremental services and third-party fees. Clinical outcomes are not consulting acceptance criteria.

A basic support product, not a replacement for a scoped major-decision commission. A self-service generated draft; individual human medical review, diagnosis, prescriptions, and emergency assessment are not included.

Keep a record of earlier assessments as your condition and the research evolve.

What the fee pays for

CNY 199 setup + CNY 69 per month. Monthly maintenance may be cancelled. New questions are quoted first; an existing record does not incur another setup fee. A 30-day read-only export period is planned after cancellation. Deletion and backup retention periods will be specified in the formal terms.

Value beyond this task

An appointment preparation checklist and exportable personal record. CNY 69 per month thereafter. You may stop maintenance and export your record even if no new records have been added. Usage beyond the allowance requires confirmation; there are no automatic additional charges.

How to assess value

Check responses to the agreed questions, traceable sources, record gaps and differing opinions. For overseas routes, also check incremental services and third-party fees. Clinical outcomes are not consulting acceptance criteria.

A basic support product, not a replacement for a scoped major-decision commission. Human consultations and real-time health monitoring are not included. The platform will not automatically instruct you to stop or switch medication.

Clarify dates, sources and differing statements in existing records before further consultation.

What the fee pays for

Scope assessment: CNY 299; focused review: CNY 699–1,999. Updates are a separate choice after the commission ends. Any credit for the assessment fee is agreed in advance; the same work is not charged twice.

Value beyond this task

Questions for further review by a clinician or lawyer. The total of CNY 1,299 includes the CNY 299 initial assessment. Charges do not depend on obtaining compensation or reimbursement.

How to assess value

Check responses to the agreed questions, traceable sources, record gaps and differing opinions. For overseas routes, also check incremental services and third-party fees. Clinical outcomes are not consulting acceptance criteria.

Accept basic record work against its source index. Consequential treatment choices require a separately scoped decision commission. Clinical opinions, forensic appraisal and judicial uses are agreed separately; no relevant fee is accepted before required personnel are confirmed.

Prepare checked facts, options and evidence for an important clinical consultation, with agreed professional review.

What the fee pays for

Proposed case-based quotation for the agreed professional appraisal. Confirm inputs and available reviewers first, then agree start, appraisal and handover payments. Retrieval, review and handover within the same scope are itemised in one quote.

Value beyond this task

Retained facts, source positions, applicability matrix, professional review records and unresolved questions. Completed reusable work is not billed twice.

How to assess value

Accept by dossier completeness, source location for key claims, completed review and clear unresolved issues.

Confirm availability, record-processing rights, reviewers and acceptance before paying. The commissioned scope does not establish superior accuracy, speed or clinical outcomes compared with OpenEvidence.

Complete one screening, extraction or analysis stage and receive actual results for review and handover.

What the fee pays for

Proposed from CNY 3,000 per defined module. Example: CNY 1,500 at start and CNY 1,500 at acceptance. Quote actual inputs, methods and review hours; clinicians and research teams use the same fee for the same scope.

Value beyond this task

Input-issue records, agreed results, method notes, figures and code for team review and subsequent research.

How to assess value

Compare software, internal hours, professional review and rework for the same module; accept the agreed results and reproducibility materials.

Default delivery covers the agreed module. Manuscript drafts and submission materials are optional and itemised. The entry price does not include a complete review; no promise of significance or acceptance.

Decide whether a study merits investment and how to proceed.

What the fee pays for

Proposed CNY 5,000–15,000 per assessment, separately commissioned after scoping. Stop after delivery if appropriate. Credit reusable work within the subsequent study quote instead of charging twice.

Value beyond this task

Topic rationale, competition and material checks, study design, scope and budget for project decisions and subsequent research.

How to assess value

Assess whether the defined question, checked competition and material, method risks and budget support a commissioning decision.

Delivery covers topic decisions and study design; complete results and manuscripts are separately scoped. Public METAQUANT research assets support discovery. Scores and research ROI are scenarios rather than realised returns or publication guarantees.

Complete one screening, extraction or analysis stage and receive actual results for review and handover.

What the fee pays for

Proposed from CNY 3,000 per defined module. Example: CNY 1,500 at start and CNY 1,500 at acceptance. Quote actual inputs, methods and review hours; clinicians and research teams use the same fee for the same scope.

Value beyond this task

Input-issue records, agreed results, method notes, figures and code for team review and subsequent research.

How to assess value

Compare software, internal hours, professional review and rework for the same module; accept the agreed results and reproducibility materials.

Default delivery covers the agreed module. Manuscript drafts and submission materials are optional and itemised. The entry price does not include a complete review; no promise of significance or acceptance.

Deliver one reproducible study around a main question, from protocol to synthesis.

What the fee pays for

Proposed CNY 60,000–150,000 per scoped project; larger or complex studies need a separate workload estimate. The fictional CNY 80,000 example includes CNY 6,000 assessment, followed by CNY 24,000, 30,000 and 20,000 stages, without a repeated assessment fee.

Value beyond this task

Complete report, source and judgement registers, data and code, methods and review records for reproduction and later updates.

How to assess value

Compare execution, professional review and third-party investment for the same scope. Accept each stage by source completeness and reproducibility.

Default delivery is a research-results package. Draft manuscripts, legends, reference checks, submission materials and revision rounds are optional and itemised in the same quote. The team agrees authorship and final submission. Findings may be negative or unsuitable for pooling; acceptance is independent of significance or publication.

Should a new pathway be piloted? Check relevant patients and local conditions first.

What the fee pays for

Planning reference: CNY 30,000–80,000 per topic; scope and review determine fees, with implementation separate.

Value beyond this task

Retain the source register, applicability table and indicator plan as the baseline for expansion.

How to assess value

Record baseline preparation hours, repeated checks and unresolved questions; compare them after delivery.

Verify reviewers, search cutoff and local-data work; a review is not an observed clinical improvement.

Teams search separately and do not know which new findings warrant another pathway discussion.

What the fee pays for

Planning reference: CNY 60,000–180,000 per department per year; additions require agreed scope.

Value beyond this task

Annual handover retains question baselines and change logs for transition to another provider.

How to assess value

Assess search time, repeated questions and evidence reuse; validate any clinical-pathway impact separately.

Check scan cadence, volume limits, response windows, sharing permissions and used hours.

Does the audit concern clinical need, payment conditions or missing records?

What the fee pays for

Planning reference: CNY 10,000–50,000 per batch, based on questions and records rather than recovered sums.

Value beyond this task

Reuse numbered indexes and verified sources in similar later reviews.

How to assess value

Track response coverage, additional-check hours and rework; reversal of deductions is not guaranteed value.

Verify jurisdiction, rule dates, original records and medical/legal responsibility.

Within a limited budget, does this technology justify payment compared with current care?

What the fee pays for

Planning reference: CNY 200,000–500,000 for evidence; full HTA from CNY 300,000–1,000,000+, with model depth scoped first.

Value beyond this task

Hand over parameters, code and sensitivity settings for later regional adaptation.

How to assess value

Measure sourced-parameter coverage, reproducibility and review rework; report budget results as uncertain scenarios.

Verify modelling/review capability, data rights and local relevance; consulting is not coverage approval.

After assessment, which new findings could materially change a coverage decision?

What the fee pays for

Planning reference: CNY 300,000–1,000,000+ annually; a missing baseline HTA is a separate project.

Value beyond this task

Retain the model, previous versions and reasons for change; renew around incremental work.

How to assess value

Count reused models/sources and avoided repeat-review hours; do not promise a payer saving percentage.

Check included model work, materiality reviewers and how absent triggers are documented.

Two policy options have advocates. How can discussion return to evidence and implementation conditions?

What the fee pays for

Planning reference: CNY 200,000–500,000 for a topic or CNY 500,000–2,000,000+ for a programme; field evaluation is separate.

Value beyond this task

Sources, assumptions and pilot indicators become reusable appraisal assets.

How to assess value

Measure option-evidence coverage, resolved questions and repeated-preparation hours; policy adoption is not acceptance.

Check local-data quality, conflicts and expert scope; association does not establish intervention effectiveness.

Recurring agendas should not require an entirely new search each time.

What the fee pays for

Planning reference: CNY 300,000–1,000,000+ annually; new policies, regions and fieldwork are separate.

Value beyond this task

Annual handover includes evidence, version differences and unresolved agendas beyond news summaries.

How to assess value

Track reused materials, repeat-agenda preparation time and expert hours; funding approval is not promised.

Specify topic limits, scanning cadence, urgent-request scheduling and procurement responsibility.

Before recommendation discussion, each finding needs sources and certainty assessment.

What the fee pays for

Planning reference: CNY 30,000–80,000 per PICO; reuse requires checking baseline quality, rights and cutoff.

Value beyond this task

Hand over evidence tables and source indexes for targeted later revision.

How to assess value

Assess locatable judgements, additional checks requested at meetings and secretariat preparation hours.

Methods review is required for certainty ratings; the authorised panel owns recommendations, conflicts and publication.

Which recommendations need reconsideration, and which do not need a complete new review?

What the fee pays for

Planning reference: CNY 60,000–150,000 annually for surveillance; resynthesis, statistics and recommendations are separate.

Value beyond this task

Retain searches, exclusion reasons, change events and prior recommendation evidence.

How to assess value

Track monitored questions, useful triggers and unnecessary repeat work avoided; do not claim automatic guideline revision.

Agree triggers, missed-record checks, ownership and update scheduling.

Does the case justify deeper medical research? Identify the key questions first.

What the fee pays for

Planning reference: CNY 5,000–15,000 initial review and CNY 1,500–4,000 per hour, logged time; agree any assessment credit.

Value beyond this task

Even without continuation, retain the questions, missing-record list and expert consultation brief.

How to assess value

Track unfocused research hours avoided, resolved questions and specialist needs; do not infer ROI from damages.

Check conflicts, authority, contemporaneous sources and medical expertise; assessment is not a litigation-success forecast.

How can a pile of records become usable material for counsel and medical experts?

What the fee pays for

Planning reference: CNY 30,000–100,000 per case or CNY 100,000–300,000+ for complex cases, by milestone; legal/appraisal/testimony fees separate.

Value beyond this task

Reuse original indexes, factual timelines, issue tables and contrary questions for expert meetings and pre-hearing preparation.

How to assess value

Measure locatable key facts, corrections, repeated counsel/expert checking hours and handover rework.

Verify originals/media, page IDs, acquisition, facts/assertions/inferences and reviewers; judicial acceptance is not guaranteed.

Recurring medical cases need stable research and record-review support.

What the fee pays for

Planning reference: CNY 200,000–800,000+ annually; specify retained capacity, overruns, unused hours and external experts.

Value beyond this task

Transfer permitted de-identified methods/literature baselines; private case records are not shared across clients.

How to assess value

Measure useful hours, repeated research avoided and timely responses; this is not unlimited all-case support.

Verify staffing, response limits, concurrency, conflicts and export on termination.

Where should research money go first to address a real development or access gap?

What the fee pays for

Planning reference: CNY 50,000–200,000 per package; trials, data and meta-analysis/ITCs require separate feasibility and fees.

Value beyond this task

Claim sources, comparison feasibility and gap priorities can transfer to internal teams or a CRO.

How to assess value

Record each study option’s cost and decision relevance, then evaluate duplicate work actually stopped or reduced.

Verify analytic capability, market requirements and rights; significance and approval are not promised.

Which new findings require changes to claims, comparisons or study plans?

What the fee pays for

Planning reference: CNY 200,000–1,000,000+ annually; full reviews, model rebuilding and new markets are separate.

Value beyond this task

Build a transferable annual product baseline with consistent source identities across teams.

How to assess value

Measure repeat-search hours, source reuse and time to human confirmation of changes; no sales-growth guarantee.

Check review cadence, medical reviewers, pharmacovigilance boundaries and response windows.

An advanced material or design is promising. How much supports the clinical claim?

What the fee pays for

Planning reference: CNY 50,000–200,000 per module or CNY 200,000–800,000+ per plan; execution is separate.

Value beyond this task

R&D, clinical and registration teams can reuse the version/claim/evidence/test matrix.

How to assess value

Track unmatched claims, reusable studies and duplicate preparation hours avoided; do not promise faster registration.

Verify market qualifications, product identity and equivalence assumptions; evidence work is not regulatory acceptance.

After a product change, does the old evidence still apply?

What the fee pays for

Planning reference: CNY 200,000–1,000,000+ annually; new purposes, markets and trials are separate projects.

Value beyond this task

Transfer old/new-version evidence maps as the baseline for later iterations.

How to assess value

Measure version-claim coverage, reassessment rework and repeated literature-check time.

Check whether vigilance and PMCF are included; do not imply completion without scope and qualifications.

A project needs one dependable evidence stage ready for client handover.

What the fee pays for

Planning reference: CNY 50,000–200,000 per package, based on volume, human review and interfaces.

Value beyond this task

Transfer screening logs, source indexes and reproducible records into the next stage.

How to assess value

Track contractor rework, acceptance rounds and handover hours saved; validate speed in real projects.

Verify subcontracting permission, end-client rights, confidentiality and actual staffing capacity.

Workload fluctuates; expert support needs a predictable schedule.

What the fee pays for

Planning reference: from CNY 240,000 annually; agree quarterly hours, unused capacity, overruns and urgent work.

Value beyond this task

Retain templates and cross-batch baselines; reused work should not be billed again.

How to assess value

Assess hours used, scheduled delivery, reused materials and procurement coordination effort.

Check staffing, reserved schedules, cover and concurrency limits; this is not an unlimited project subscription.

There are many ingredient papers. Do they support this finished product’s specific claim?

What the fee pays for

Quoted by scope; separate claim review, protocol, analysis and updates from testing, recruitment and execution.

Value beyond this task

Reuse channel Q&A, source indexes and ingredient/product maps; assess formula changes incrementally.

How to assess value

Track unsupported claims revised/withdrawn, repeat-check hours avoided and next-study budgets; measure sales impact separately.

Verify finished-product, population and dose matching plus market review; no guaranteed positive findings or certification.

Users enjoy the experience. Does that demonstrate better sleep or lower stress?

What the fee pays for

Quote source review, measurement design and expert review; licenses, recruitment, delivery and safety assurance are separate.

Value beyond this task

Reuse purchaser summaries, outcome plans and version maps for procurement review and future studies.

How to assess value

Measure resolved procurement questions, planned evaluation measures and reusable assets; do not promise effect percentages in advance.

Verify mental/sleep reviewers; method-level evidence does not establish product effects or crisis-service qualifications.

Where is the gap between product parameters, user experience and a health benefit?

What the fee pays for

Quoted by scope; evidence review and protocol first, with venue, device testing and execution budgets separate.

Value beyond this task

Reuse version identities, measures and consumer Q&A when sites or parameters change.

How to assess value

Track avoidable study spend, repeat preparation and claim rework; measure experience/health benefits in studies.

Check service/product boundaries, actual parameters and adverse experiences; no healing certification or predetermined ranking.

A procurement agent should see evidence and limitations alongside marketing.

What the fee pays for

Planned service quoted by scope; file delivery, maintenance and real API integration are separate projects.

Value beyond this task

Human summaries and JSON reuse sources; new channels do not need a separately invented medical claim set.

How to assess value

Measure readability, source parsing and manual-check time first; conversion and distribution require real integration.

No live integration, certification or automatic orders; validate recipient fields, source rights and human authorisation first.